Cancer – ANBL00B1: Neuroblastoma Biology Studies
Condition or Therapy:
Ganglioneuroblastoma, localized neuroblastoma
Cancer and Blood Disorders
Study Number: ANBL00B1
What is the goal of this study?
This study looks at biomarkers in patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.
Who can join the study?
This study may be a good fit for children and young adults who:
- are up to 30 years old,
- have been newly diagnosed with neuroblastoma or ganglioneuroblastoma, and
- have not received chemotherapy yet.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.